Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John M Magenau, MD
University of Michigan, Department of Internal Medicine
Principal Investigator - Shin Mineishi, MD
University of Alabama at Birmingham
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital for Sick Children
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- University of Alabama, Birmingham
Birmingham, Alabama, United States
- City of Hope National Medical Center
Duarte, California, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- University of Michigan Cancer Center
Ann Arbor, Michigan, United States
- Washington University at St Louis
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Vanderbuilt University
Nashville, Tennessee, United States
- University of Washington
Seattle, Washington, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2011
- Primary completion
- 30 Nov 2014
- Completion
- 14 Jun 2016
- Last update posted
- 2 Jun 2017
- Registered enrollment
- 75
- Registry id
- NCT01457885
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.